Anika Therapeutics, Inc. | Anika Therapeutics | Massachusetts | state | 2012 | undisclosed | | tax credit/rebate |
Animas Corporation | Johnson & Johnson | Pennsylvania | state | 2008 | $84,072 | | tax credit/rebate |
Animas Corporation | Johnson & Johnson | Pennsylvania | state | 2009 | $28,118 | | tax credit/rebate |
Apotex Corporation | Apotex Corp. | Illinois | state | 2004 | $22,500 | | grant |
Aptalis Pharma US, Inc. & Aptalis Pharmatech, Inc. | AbbVie | New Jersey | state | 2008 | $579,072 | | grant |
APTALIS PHARMATECH INC | AbbVie | Ohio | state | 2008 | $20,000 | | grant |
APTALIS PHARMATECH INC | AbbVie | Ohio | state | 2013 | $25,390 | | training reimbursement |
APTALIS PHARMATECH INC | AbbVie | Ohio | state | 2014 | $159,943 | | grant |
Aralez Pharmaceuticals US, Inc. | Miravo Healthcare | New Jersey | state | 2016 | $5,625,000 | | tax credit/rebate |
ARIAD Pharmaceuticals, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2013 | $1,225,000 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | North Carolina | state | 2013 | $7,529 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | North Carolina | state | 2016 | $15,140 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | Pennsylvania | state | 2017 | $19,037 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | North Carolina | state | 2017 | $15,140 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | North Carolina | state | 2021 | $3,478 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | North Carolina | state | 2019 | $9,216 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | North Carolina | state | 2022 | $12,182 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | North Carolina | state | 2018 | $17,353 | | tax credit/rebate |
Astellas Pharma Manufacturing Inc (Formerly Fujisawa Healthcare, Inc.) | Astellas Pharma | New York | local | 2006 | $101,286 | | tax credit/rebate; property tax abatement |
Astellas Pharma Manufacturing Inc (Formerly Fujisawa Healthcare, Inc.) | Astellas Pharma | New York | local | 2006 | $56,648 | | tax credit/rebate; property tax abatement |
Astellas Pharma Manufacturing Inc (Formerly Fujisawa Healthcare, Inc.) | Astellas Pharma | New York | local | 2006 | $35,965 | | tax credit/rebate; property tax abatement |
Astellas Pharma Manufacturing, Inc. | Astellas Pharma | New York | local | 2007 | $103,752 | | tax credit/rebate; property tax abatement |
Astellas Pharma Manufacturing, Inc. | Astellas Pharma | New York | local | 2007 | $54,956 | | tax credit/rebate; property tax abatement |
Astellas Pharma Manufacturing, Inc. | Astellas Pharma | New York | local | 2007 | $36,845 | | tax credit/rebate; property tax abatement |
Astellas Pharma US, Inc. | Astellas Pharma | Maryland | state | 2007 | $1,236 | | tax credit/rebate |
Astellas Research Institute of America | Astellas Pharma | Illinois | state | 2007 | undisclosed | | tax credit/rebate |
Astellas Research Institute of America | Astellas Pharma | Illinois | state | 2008 | undisclosed | | tax credit/rebate |
Astellas Research Institute of America | Astellas Pharma | Illinois | state | 2009 | $62,980 | | tax credit/rebate |
Astellas Research Institute of America | Astellas Pharma | Illinois | state | 2010 | $96,488 | | tax credit/rebate |
Astellas US Holding, Inc | Astellas Pharma | Illinois | state | 2005 | $137,500 | | grant |
Astellas US Holding, Inc | Astellas Pharma | Illinois | state | 2006 | $87,250 | | grant |
Astellas US Holding, Inc | Astellas Pharma | Illinois | state | 2008 | $30,000 | | grant |
Astellas US Holding, Inc | Astellas Pharma | Illinois | state | 2007 | $500,000 | | grant |
Astellas US Holding, Inc. | Astellas Pharma | Illinois | state | 2006 | $1,060,334 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Illinois | state | 2007 | $1,060,334 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Illinois | state | 2008 | $1,605,983 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Illinois | state | 2009 | $1,605,983 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Illinois | state | 2010 | $1,605,983 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Maryland | state | 2011 | $15,463 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Maryland | state | 2012 | $74,558 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Maryland | state | 2014 | $74,558 | | tax credit/rebate |
Astellas US LLC | Astellas Pharma | United States | federal | 2013 | $1,160,482 | | federal grant |
Astellas US LLC and its subsidiaries and related entities | Astellas Pharma | Illinois | state | 2014 | $3,398,678 | | tax credit/rebate |
Astellas US LLC and its subsidiaries and related entities | Astellas Pharma | Illinois | state | 2013 | $1,383,958 | | tax credit/rebate |
Astellas US LLC and its subsidiaries and related entities | Astellas Pharma | Illinois | state | 2015 | $3,701,242 | | tax credit/rebate |
Astellas US LLC and its subsidiaries and related entities | Astellas Pharma | Illinois | state | 2016 | $4,515,115 | | tax credit/rebate |
Astra Zeneca Pharmaceutical | AstraZeneca | Delaware | state | 2005 | $14,972 | | training reimbursement |
Astra Zeneca Pharmaceutical | AstraZeneca | Delaware | state | 2006 | $16,820 | | training reimbursement |
Astra Zeneca Pharmaceutical | AstraZeneca | Delaware | state | 2007 | $6,650 | | training reimbursement |
Astra Zeneca Pharmaceutical | AstraZeneca | Delaware | state | 2008 | $16,264 | | training reimbursement |
Astra Zeneca Pharmaceutical | AstraZeneca | Delaware | state | 2009 | $7,195 | | training reimbursement |
Astra Zeneca Pharmaceutical | AstraZeneca | Delaware | state | 2010 | $47,404 | | training reimbursement |
Astra Zeneca Pharmaceutical | AstraZeneca | Delaware | state | 2012 | $20,276 | | training reimbursement |
AstraZeneca | AstraZeneca | Delaware | multiple | 1999 | $178,000,000 | | MEGADEAL |
AstraZeneca Pharmaceuticals | AstraZeneca | Delaware | state | 2016 | $5,868 | | training reimbursement |
AstraZeneca Pharmaceuticals LP | AstraZeneca | United States | federal | 2012 | $2,713,491 | | federal grant |
AstraZeneca Pharmaceuticals LP | AstraZeneca | Indiana | state | 2017 | $600,000 | | tax credit/rebate |
AstraZeneca Pharmaceuticals LP | AstraZeneca | Indiana | state | 2017 | $200,000 | | training reimbursement |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | Maryland | state | 2017 | $534,013 | | tax credit/rebate |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | Maryland | state | 2018 | $2,161,115 | | tax credit/rebate |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | Maryland | state | 2019 | $1,338,392 | | tax credit/rebate |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | Maryland | state | 2020 | $1,629,414 | | tax credit/rebate |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | Maryland | state | 2021 | $1,461,100 | | tax credit/rebate |
Astrazeneca Pharmaceuticals, Lp | AstraZeneca | Maryland | state | 2022 | $250,000 | | tax credit/rebate |
Auxilium Pharmaceuticals Inc. | Endo International | Pennsylvania | state | 2008 | $129,688 | | tax credit/rebate |
Auxilium Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | | $60,000 | | grant |
Auxilium Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2015 | $66,990 | | tax credit/rebate |
Auxilium Pharmacueticals, Inc. | Endo International | Pennsylvania | state | 2013 | $465,755 | | tax credit/rebate |
Auxilium Pharmacueticals, Inc. | Endo International | Pennsylvania | state | 2014 | $426,723 | | tax credit/rebate |
Auxillum Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | | $120,000 | | tax credit/rebate |
AVANIR PHARMACEUTICALS INC | Otsuka Pharmaceutical | California | state | 2017 | $12,225 | | training reimbursement |
Aventis Pasteur Inc. | Sanofi | Pennsylvania | state | | $810,000 | | tax credit/rebate |
Aventis Pasteur Inc. | Sanofi | Pennsylvania | state | | $1,000,000 | | grant |
Aventis Pasteur USA | Sanofi | Pennsylvania | state | | $509,900 | | training reimbursement |
Aventis Pasteur USA | Sanofi | Pennsylvania | state | | $500,000 | | grant |
Aventis Pharmaceuticals | Sanofi | Missouri | local | 2007 | $338,637 | | tax increment financing |
Aventis Pharmaceuticals | Sanofi | Missouri | local | 2008 | $2,507,992 | | tax increment financing |
Aventis Pharmaceuticals | Sanofi | Missouri | local | 2010 | $2,288,978 | | tax increment financing |
Aventis Pharmaceuticals | Sanofi | Missouri | local | 2011 | $2,224,018 | | tax increment financing |
Aventis Pharmaceuticals | Sanofi | Missouri | local | 2012 | $2,352,115 | | tax increment financing |
Aventis Pharmaceuticals | Sanofi | Missouri | local | 2015 | $1,375,894 | | tax increment financing |
AVID Radiopharaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2007 | $100,000 | | tax credit/rebate |
AVID RADIOPHARMACEUTICALS INC | Eli Lilly | Pennsylvania | state | 2020 | $9,000 | | tax credit/rebate |
Avid Radiopharmaceuticals Inc | Eli Lilly | Pennsylvania | state | 2021 | $28,300 | | tax credit/rebate |
Avid Radiopharmaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2008 | $101,627 | | tax credit/rebate |
Avid Radiopharmaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2009 | $123,461 | | tax credit/rebate |
Avid Radiopharmaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2010 | $48,077 | | tax credit/rebate |
Avid Radiopharmaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2011 | $159,381 | | tax credit/rebate |
Avid Radiopharmaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2010 | $100,000 | | tax credit/rebate |
Avid Radiopharmaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2009 | $100,000 | | tax credit/rebate |
AVID Radiopharmaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2008 | $100,000 | | tax credit/rebate |
Avid Radiopharmaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2006 | $100,000 | | tax credit/rebate |
AXIS SHIELD DIAGNOSTICS LIMITED | Abbott Laboratories | Washington | state | 2011 | $4,930 | | tax credit/rebate |
Barr Laboratories Inc. | Teva Pharmaceutical Industries | Virginia | state | 2008 | $500,000 | | grant |
Barr Laboratories, Inc. | Teva Pharmaceutical Industries | Virginia | state | 2008 | $400,000 | | grant |
Barr Laboratories, Inc. and Subsidiaries | Teva Pharmaceutical Industries | New Jersey | state | 2002 | $1,969,200 | | grant |
Bausch & Lomb | Bausch Health | New York | local | 2003 | $266,156 | | tax credit/rebate; property tax abatement |
Bausch & Lomb | Bausch Health | New York | local | 2004 | $214,683 | | tax credit/rebate; property tax abatement |
Bausch & Lomb | Bausch Health | New York | local | 2005 | $145,551 | | tax credit/rebate; property tax abatement |
Bausch & Lomb | Bausch Health | Florida | state | 2010 | $50,000 | | training reimbursement |
Bausch & Lomb | Bausch Health | Florida | state | 2012 | $47,493 | | training reimbursement |